De novo bone regeneration in human extraction sites using recombinant human bone morphogenetic protein-2/ACS: a clinical, histomorphometric, densitometric, and 3-dimensional cone-beam computerized tomographic scan evaluation

Implant Dent. 2014 Apr;23(2):132-7. doi: 10.1097/ID.0000000000000035.

Abstract

Introduction: To preserve alveolar bone after extractions, it is important to graft socket sites to prevent bone loss from repair and remodeling.

Objective: The objective of this case series was to assess the clinical, densitometric, and histomorphometric results from extraction sockets treated with recombinant human bone morphogenetic protein (rhBMP-2/ACS).

Study design: After extraction and socket debridement, INFUSE (rhBMP-2) on absorbable sponges was placed over each socket. After 4 months, 3-dimensional cone-beam computerized tomographic (CT) scans were taken. Trephined bone cores were taken as the first step in the implant site osteotomy and submitted for histomorphometric analysis.

Results: Histomorphometric analysis showed a mean of 49.6% vital bone with a SD of 10.8%. CT scans showed mean density of 510.6 Hounsfield units.

Conclusions: Use of INFUSE in socket preservation surgery results in adequate de novo bone formation to support ideal implant placement after 4 months.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Morphogenetic Protein 2 / therapeutic use*
  • Bone Regeneration / drug effects*
  • Cone-Beam Computed Tomography
  • Dental Implantation / methods
  • Humans
  • Middle Aged
  • Recombinant Proteins
  • Tooth Extraction / adverse effects
  • Tooth Socket / diagnostic imaging
  • Tooth Socket / drug effects*
  • Tooth Socket / growth & development
  • Tooth Socket / pathology
  • Young Adult

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Recombinant Proteins